SE440647B - Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol - Google Patents

Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol

Info

Publication number: SE440647B
Authority: SE; Sweden
Prior art keywords: dichlorphenoxy; butylamino; propanol; tert; prepare
Prior art date: 1976-03-02

Application number

SE7702251A

Other languages

English (en)

Other versions

SE7702251L (sv

Inventor

A Hajos

M Fekete

M Kurti

T Lang

L Toldy

J Borvendeg

L Nagy

S Elek

I Polgari

I Elekes

Original Assignee

Richter Gedeon Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-03-02

Filing date

1977-03-01

Publication date

1985-08-12

1977-03-01 Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet

1977-09-03 Publication of SE7702251L publication Critical patent/SE7702251L/sv

1985-08-12 Publication of SE440647B publication Critical patent/SE440647B/sv

Links

XYCMOTOFHFTUIU-UHFFFAOYSA-N cloranolol Chemical compound CC(C)(C)NCC(O)COC1=CC(Cl)=CC=C1Cl XYCMOTOFHFTUIU-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Emergency Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Epoxy Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SE7702251A 1976-03-02 1977-03-01 Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol SE440647B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU76GO00001331A HU172137B (hu)	1976-03-02	1976-03-02	Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina

Publications (2)

Publication Number	Publication Date
SE7702251L SE7702251L (sv)	1977-09-03
SE440647B true SE440647B (sv)	1985-08-12

Family

ID=10996805

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7702251A SE440647B (sv)	1976-03-02	1977-03-01	Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol

Country Status (25)

Country	Link
US (1)	US4310549A (sv)
JP (1)	JPS5923299B2 (sv)
AT (1)	AT348507B (sv)
AU (1)	AU508766B2 (sv)
BE (1)	BE851938A (sv)
CA (1)	CA1091254A (sv)
CH (1)	CH627732A5 (sv)
CS (1)	CS190340B2 (sv)
DD (1)	DD128610A5 (sv)
DE (1)	DE2709109C3 (sv)
DK (1)	DK143554C (sv)
FI (1)	FI65231C (sv)
FR (1)	FR2342956A1 (sv)
GB (1)	GB1573191A (sv)
HU (1)	HU172137B (sv)
IL (1)	IL51574A (sv)
IN (1)	IN144243B (sv)
KE (1)	KE3340A (sv)
MY (1)	MY8500104A (sv)
NL (1)	NL7702170A (sv)
NO (1)	NO141989C (sv)
PL (1)	PL103734B1 (sv)
SE (1)	SE440647B (sv)
SU (1)	SU648080A3 (sv)
YU (1)	YU40813B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004106299A2 (en) *	2003-05-30	2004-12-09	Ranbaxy Laboratories Limited	Substituted pyrrole derivatives and their use as hmg-co inhibitors
KR101329112B1 (ko) *	2005-11-08	2013-11-14	랜박시 래보러터리스 리미티드	(3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
WO2008020314A2 (en) *	2006-03-14	2008-02-21	Ranbaxy Laboratories Limited	Statin stabilizing dosage formulations
MX2009000439A (es) *	2006-07-14	2009-02-04	Ranbaxy Lab Ltd	Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH569692A5 (sv)	1971-03-17	1975-11-28	Richter Gedeon Vegyeszet
US4067904A (en) *	1975-12-19	1978-01-10	Mead Johnson & Company	Alkylsulfonylphenoxypropanolamine derivatives

1976
- 1976-03-02 HU HU76GO00001331A patent/HU172137B/hu not_active IP Right Cessation
1977
- 1977-02-25 CH CH235877A patent/CH627732A5/de unknown
- 1977-02-28 AT AT134177A patent/AT348507B/de not_active IP Right Cessation
- 1977-03-01 CS CS771363A patent/CS190340B2/cs unknown
- 1977-03-01 SU SU772457128A patent/SU648080A3/ru active
- 1977-03-01 FR FR7705898A patent/FR2342956A1/fr active Granted
- 1977-03-01 CA CA272,912A patent/CA1091254A/en not_active Expired
- 1977-03-01 DD DD7700197617A patent/DD128610A5/xx unknown
- 1977-03-01 IL IL51574A patent/IL51574A/xx unknown
- 1977-03-01 YU YU549/77A patent/YU40813B/xx unknown
- 1977-03-01 NO NO770688A patent/NO141989C/no unknown
- 1977-03-01 GB GB8593/77A patent/GB1573191A/en not_active Expired
- 1977-03-01 BE BE1007979A patent/BE851938A/xx not_active IP Right Cessation
- 1977-03-01 DK DK88577A patent/DK143554C/da not_active IP Right Cessation
- 1977-03-01 NL NL7702170A patent/NL7702170A/xx not_active Application Discontinuation
- 1977-03-01 IN IN292/CAL/77A patent/IN144243B/en unknown
- 1977-03-01 PL PL1977196357A patent/PL103734B1/pl unknown
- 1977-03-01 FI FI770651A patent/FI65231C/fi not_active IP Right Cessation
- 1977-03-01 SE SE7702251A patent/SE440647B/sv not_active IP Right Cessation
- 1977-03-01 AU AU22795/77A patent/AU508766B2/en not_active Expired
- 1977-03-02 DE DE2709109A patent/DE2709109C3/de not_active Expired
- 1977-03-02 JP JP52021640A patent/JPS5923299B2/ja not_active Expired
1979
- 1979-09-04 US US06/072,295 patent/US4310549A/en not_active Expired - Lifetime
1983
- 1983-10-24 KE KE3340A patent/KE3340A/xx unknown
1985
- 1985-12-30 MY MY104/85A patent/MY8500104A/xx unknown

Also Published As

Publication number	Publication date
IN144243B (sv)	1978-04-15
SE7702251L (sv)	1977-09-03
YU40813B (en)	1986-06-30
NL7702170A (nl)	1977-09-06
DD128610A5 (de)	1977-11-30
DK143554B (da)	1981-09-07
JPS52122328A (en)	1977-10-14
FI770651A (sv)	1977-09-03
AT348507B (de)	1979-02-26
FI65231B (fi)	1983-12-30
HU172137B (hu)	1978-06-28
IL51574A (en)	1980-01-31
SU648080A3 (ru)	1979-02-15
AU508766B2 (en)	1980-04-03
FI65231C (fi)	1984-04-10
JPS5923299B2 (ja)	1984-06-01
NO141989B (no)	1980-03-03
DE2709109A1 (de)	1977-09-15
BE851938A (fr)	1977-09-01
FR2342956A1 (fr)	1977-09-30
CH627732A5 (de)	1982-01-29
KE3340A (en)	1983-11-25
IL51574A0 (en)	1977-05-31
MY8500104A (en)	1985-12-31
AU2279577A (en)	1978-09-07
US4310549A (en)	1982-01-12
CS190340B2 (en)	1979-05-31
ATA134177A (de)	1978-07-15
FR2342956B1 (sv)	1982-11-26
DE2709109B2 (de)	1980-01-17
NO770688L (no)	1977-09-05
CA1091254A (en)	1980-12-09
GB1573191A (en)	1980-08-20
DK143554C (da)	1982-03-08
YU54977A (en)	1982-10-31
PL103734B1 (pl)	1979-07-31
DK88577A (da)	1977-09-03
NO141989C (no)	1980-06-11
DE2709109C3 (de)	1980-09-18

Legal Events

Date

Code

Title

Description

1995-01-31

NAL

Patent in force

Ref document number: 7702251-5

Format of ref document f/p: F

1995-12-04

NUG

Patent has lapsed